FERMENTED GINSENG RADIX ET RHIZOMA EXTRACT, PRODUCT FOR ALLEVIATING NON-ALCOHOLIC FATTY LIVER DISEASE, METHOD FOR PROMOTING INCREASE OF CONTENT OF AGLYCONE FLAVONOIDS AND/OR SHORT-CHAIN FATTY ACIDS IN GINSENG RADIX ET RHIZOMA EXTRACT, AND METHOD FOR PROMOTING EFFICACY OF GINSENG RADIX ET RHIZOMA EXTRACT IN ALLEVIATING NON-ALCOHOLIC FATTY LIVER DISEASE
Number of patents in Portfolio can not be more than 2000
United States of America
Stats
-
N/A
Issued Date -
Mar 13, 2025
app pub date -
Jun 18, 2024
filing date -
Jun 18, 2024
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
The present invention discloses use of Bifidobacterium animalis subsp.lactis in promoting efficacy exertion of a Ginseng Radix Et Rhizoma extract in alleviating liver injuries. According to the present invention, Bifidobacterium animalis subsp.lactis CCFM1274 may grow in a fermentation base rich in a Ginseng Radix Et Rhizoma extract, and a fermentation broth of the Ginseng Radix Et Rhizoma extract fermented with this strain can increase the content of active substances such as aglycone flavonoids and short-chain fatty acids, promote the efficacy exertion of the Ginseng Radix Et Rhizoma extract, including improving the ability of the Ginseng Radix Et Rhizoma extract to alleviate a non-alcoholic liver injury, and reduce the fat accumulation in liver cells. This strain and the Ginseng Radix Et Rhizoma extract may be used to prepare a product for promoting the efficacy of alleviating the non-alcoholic liver injury.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully